Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)
Clinical trial NCT03345914 · COMPLETED
Trial details
- NCT number
- NCT03345914
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-17
- Primary completion
- 2019-06-20
- Enrollment
- 367
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.